Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Physical interaction of the retinoblastoma protein with human d-cyclins

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Dowdy, S. F.
  • Hinds, P. W.
  • Louie, K.
  • Reed, Steven
  • Arnold, A.
  • Weinberg, R. A.

publication date

  • May 1993

journal

  • Cell  Journal

abstract

  • The retinoblastoma protein (pRb) functions as a regulator of cell proliferation and in turn is regulated by cyclin-dependent kinases. Cyclins D1 and D3 can form complexes with pRb that resemble those formed by several viral oncoproteins and are disrupted by the adenovirus E1A oncoprotein and derived peptides. These cyclins contain a sequence motif similar to the pRb-binding conserved region II motif of the viral oncoproteins. Alteration of this motif in cyclin D1 prevents formation of cyclin D1-pRb complexes while enhancing the biological activity of cyclin D1 assayed in vivo. We conclude that cyclins D1 and D3 interact with pRb in a fashion distinct from cyclins A and E, which can induce pRb hyperphosphorylation, and that cyclin D1 activity may be regulated by its association with pRb.

subject areas

  • Amino Acid Sequence
  • Base Sequence
  • Cell Cycle
  • Chromosome Mapping
  • Cyclin D1
  • Cyclin D2
  • Cyclin D3
  • Cyclins
  • Genes, Retinoblastoma
  • Humans
  • Molecular Sequence Data
  • Oncogene Proteins
  • Osteosarcoma
  • Phosphorylation
  • Retinoblastoma Protein
  • Sequence Homology, Amino Acid
  • Transfection
  • Tumor Cells, Cultured
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0092-8674

Digital Object Identifier (DOI)

  • 10.1016/0092-8674(93)90137-f

PubMed ID

  • 8490963
scroll to property group menus

Additional Document Info

start page

  • 499

end page

  • 511

volume

  • 73

issue

  • 3

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support